Indications and uses
For daily defense against head lice infestations.
Vamousse Lice Defense
- Manufacturer
- Alliance Pharma Inc.
- Effective date
- 2024-10-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 02:28:13
Label at a glance#
ProductVamousse Lice Defense
Active ingredientEUCALYPTUS GLOBULUS LEAF, SODIUM CHLORIDE
Label structure9 sections
Dosage and administration
Adults and children 2 years and older: • Apply a generous amount of shampoo to wet hair, work into a lather and massage into scalp. Leave shampoo in hair for at least 3 minutes. Rinse. • For defense against a head lice infestation, use daily for at least 10 to 14 days to kill any lice that may have hatched. • For an active head lice infestation, use Vamousse ® Lice Treatment before using this shampoo. Children und...
Contacts and useful links#
Websitewww.vamousselice.com
www.VamousseLice.com
www.VamousseLice.comLabel contents#
Full prescribing information#
Active Ingredients
Eucalyptus globulus 2X (HPUS)
Natrum muriaticum 2X (HPUS)
Purpose
Pediculicide
Uses
For daily defense against head lice infestations.
Warnings
For external use only.
Do not use• near eyes • inside nose or mouth • on eyebrows or eyelashes. See a doctor if lice are present in these areas. Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
When using this product:
• Do not use in or near the eyes. Close eyes while applying.
• Do not permit contact with mucous membranes, such as inside the nose, as irritation or stinging may occur.
Stop use and ask a doctor• if eye irritation occurs • skin or scalp irritation or infection occurs.
If pregnant or breast-feeding,ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.
Directions:
Adults and children 2 years and older:
• Apply a generous amount of shampoo to wet hair, work into a lather and massage into scalp. Leave shampoo in hair for at least 3 minutes. Rinse.
• For defense against a head lice infestation, use daily for at least 10 to 14 days to kill any lice that may have hatched.
• For an active head lice infestation, use Vamousse ®Lice Treatment before using this shampoo.
Children under 2 years: ask a doctor.
Product may be used as often as needed.
Inactive Ingredients
Water, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, Sodium Cocoyl Isethionate, Cocamide DIPA, Benzyl Alcohol, Butyl Lactate, Citric Acid Anhydrous, Polyquaternium-10, Tetrasodium EDTA, Propylene Glycol, Diazolidinyl Urea, Iodopropynyl Butylcarbamate, PEG-150 Pentaerythrityl Tetrastearate, PEG-6 Caprylic/Capric Glycerides, Tea Tree Oil, Eucalyptus Oil, Geraniol, Isopropyl myristate, Fragrance
Questions?
1.855.373.7210 or www.VamousseLice.com
Call to report serious side effects
SPL UNCLASSIFIED SECTION
PESTICIDE - FREE
Kill Stray Super Lice*
Before Detected
with Tea Tree Oil
Defends Family Against Lice Infestation
CLINICALLY PROVEN
Use After Exposure or Treatment
Follow-up with Favorite Conditioner
No Parabens, Sulfates or Dyes
HOMEOPATHIC
*As shown in lab studies
Manufactured for: ALLIANCE
Alliance Pharma Inc., Cary, NC 27518
Made in the U.S.A Vamousse, Alliance and associated devices are trade marks of Alliance Pharmaceuticals Limited
Packaging
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72238-004-01 | 2023-06-14 | C162847 | 48780-1 | f386c649-a7fd-0266-e053-dadaa90a7c1a | VAMOUSSE ® LICE DEFENSE DAILY SHAMPOO |
| 72238-004-03 | 2023-06-14 | C162847 | 48780-1 | f386c649-a7fd-0266-e053-dadaa90a7c1a | VAMOUSSE ® LICE DEFENSE DAILY SHAMPOO |
| 72238-004-01 | 2023-01-30 | C162847 | 48780-1 | f386c649-a7fd-0266-e053-dadaa90a7c1a | VAMOUSSE ® LICE DEFENSE DAILY SHAMPOO |
| 72238-004-03 | 2023-01-30 | C162847 | 48780-1 | f386c649-a7fd-0266-e053-dadaa90a7c1a | VAMOUSSE ® LICE DEFENSE DAILY SHAMPOO |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72238-004-01 | Vamousse Lice Defense | 295 mL in 1 BOTTLE | SHAMPOO | 295 | 5 | |
| 72238-004-02 | Vamousse Lice Defense | 118 mL in 1 BOTTLE | SHAMPOO | 118 | 5 | |
| 72238-004-03 | Vamousse Lice Defense | 400 mL in 1 BOTTLE | SHAMPOO | 400 | 5 | |
| 72238-004-05 | Vamousse Lice Defense | 250 mL in 1 BOTTLE | SHAMPOO | 250 | 5 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Vamousse Lice Defense
- Eucalyptus globulus, Natrum muriaticum
- SODIUM C14-16 OLEFIN SULFONATE
- COCAMIDOPROPYL BETAINE
- SODIUM COCOYL ISETHIONATE
- PEG-150 PENTAERYTHRITYL TETRASTEARATE
- CAPRYLOCAPROYL POLYOXYLGLYCERIDES 6
- COCO DIISOPROPANOLAMIDE
- TEA TREE OIL
- BENZYL ALCOHOL
- EUCALYPTUS OIL
- BUTYL LACTATE
- ANHYDROUS CITRIC ACID
- POLYQUATERNIUM-10 (125 MPA.S AT 2%)
- GERANIOL
- EDETATE SODIUM
- ISOPROPYL MYRISTATE
- EUCALYPTUS GLOBULUS LEAF
- SODIUM CHLORIDE
- CHLORIDE ION
- WATER
- PROPYLENE GLYCOL
- DIAZOLIDINYL UREA
- IODOPROPYNYL BUTYLCARBAMATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72238-004 | 72238-004-01, 72238-004-03, 72238-004-05, 72238-004-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vamousse Lice Defense | EUCALYPTUS GLOBULUS, NATRUM MURIATICUM | Alliance Pharma Inc. | c87ce5d3-c200-421e-88be-bc8060a5993a | 2024-10-08 | Warnings | 72238-004-01 72238-004-02 72238-004-03 72238-004-05 72238-004 72238000402 72238000403 72238000401 72238000405 23fcd746-aca1-d666-e063-6394a90a62a5 c87ce5d3-c200-421e-88be-bc8060a5993a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.